title: Avoidance of Toxoplasma gondii transmission from a recently infected donor to the recipient of hematopoietic stem cell transplantation.
authors.forename: M P
authors.initials: MP
authors.lastname: Brenier-Pinchart
authors.forename: F
authors.initials: F
authors.lastname: Garban
authors.forename: H
authors.initials: H
authors.lastname: Fricker-Hidalgo
authors.forename: M J
authors.initials: MJ
authors.lastname: Richard
authors.forename: C
authors.initials: C
authors.lastname: Makowski
authors.forename: H
authors.initials: H
authors.lastname: Pelloux
mesh_terms: D000328:Adult; D005260:Female; D018380:Hematopoietic Stem Cell Transplantation / Q000009:adverse effects* / Q000379:methods; D006801:Humans; D015572:Spiramycin / Q000627:therapeutic use; D014019:Tissue Donors; D014123:Toxoplasmosis / Q000517:prevention & control* / Q000635:transmission; D014184:Transplantation, Homologous
chemical_list: D015572:Spiramycin